Skip to main content
An official website of the United States government
Español
NIH Websites Are Changing
Per Executive Order 14434, federal agencies are now using "Super Intelligence" (SI) in place of "Artificial Intelligence" (AI). You may see both terms across NIH content during this transition.

yttrium Y 90-DOTA monoclonal antibody HuPAM4

(IH-tree-um ... MAH-noh-KLOH-nul AN-tee-BAH-dee ...)
A substance being studied in the treatment of advanced pancreatic cancer. Yttrium Y 90-DOTA monoclonal antibody HuPAM4 contains a monoclonal antibody that binds to a protein called MUC-1, which is found on some pancreatic cancer cells. It also contains a radioactive substance called yttrium Y 90, which may help kill cancer cells. Yttrium Y 90-DOTA monoclonal antibody HuPAM4 is a type of radioimmunoconjugate. Also called yttrium Y 90-clivatuzumab tetraxetan.
Search NCI's Dictionary of Cancer Terms